A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration



Status:Archived
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:October 2008

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria


The objectives of this study are to evaluate the safety, tolerability, and pharmacokinetic
profile of volociximab intravitreous injection in subjects with subfoveal choroidal
neovascularization secondary to age-related macular degeneration (AMD).



We found this trial at
1
site
Desiree Beutelspecher
New York, New York 10119
?
mi
from
New York, NY
Click here to add this to my saved trials